Drug intelligence / Profile preview

PheoniX

Development stage
Unknown
Lead developer
Legion Athletics
Modality
Small Molecules
Administration
Oral
01

Overview

PheoniX is a multi-ingredient dietary supplement marketed primarily as a stimulant-free fat burner. It is designed to support weight loss through several distinct biological pathways without the use of caffeine or other traditional stimulants. The formulation typically includes synephrine, naringin, and hesperidin, which are intended to stimulate the beta-3 adrenergic receptors and increase the basal metabolic rate. Additionally, it contains forskolin, which activates the enzyme adenylyl cyclase, thereby increasing intracellular levels of cyclic adenosine monophosphate (cAMP) to promote lipolysis. Other components like epigallocatechin gallate (EGCG) inhibit catechol-O-methyltransferase (COMT) to prolong the activity of fat-burning hormones, while 5-HTP is included to support serotonin production and potentially reduce appetite. The product is developed and marketed by Legion Athletics.

Brand names
PheoniX
Other names
Legion PheoniX
02

Targets

COMT (Catechol-O-methyltransferase)ADRB3 (β3)AC (Adenylyl cyclase family)

Beyond the preview

Go deeper on PheoniX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PheoniX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call